This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Mar 27;95(6):e33-4.

doi: 10.1097/TP.0b013e3182846013.

Reply to "Defining the benefits of desensitization therapy"

Kwaku Marfo, Enver Akalin

PMID: 23507653
DOI: 10.1097/TP.0b013e3182846013

Comment

Reply to "Defining the benefits of desensitization therapy"

Kwaku Marfo et al. Transplantation. 2013.

. 2013 Mar 27;95(6):e33-4.

doi: 10.1097/TP.0b013e3182846013.

Authors

Kwaku Marfo, Enver Akalin

PMID: 23507653
DOI: 10.1097/TP.0b013e3182846013

No abstract available

PubMed Disclaimer

Comment on

Lack of effect in desensitization with intravenous immunoglobulin and rituximab in highly sensitized patients.
Marfo K, Ling M, Bao Y, Calder B, Ye B, Hayde N, Greenstein S, Chapochnick-Friedman J, Glicklich D, de Boccardo G, Kinkhabwala M, Akalin E. Marfo K, et al. Transplantation. 2012 Aug 27;94(4):345-51. doi: 10.1097/TP.0b013e3182590d2e. Transplantation. 2012. PMID: 22820699
Defining the benefits of desensitization therapy.
Jordan SC, Vo A, Lai CH, Reinsmoen N. Jordan SC, et al. Transplantation. 2013 Mar 27;95(6):e31-2. doi: 10.1097/TP.0b013e3182845fe1. Transplantation. 2013. PMID: 23507651 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information